Statewide Unified Network for Remote Intervention of Strength and Exercise (SUNRISE)
This study will evaluate whether a remotely delivered exercise program can improve chemotherapy tolerability in patients with gastrointestinal or lung cancer receiving chemotherapy.
In this decentralized, digital randomized clinical trial, up to 120 adults with gastrointestinal or lung cancer will be randomized to either a home-based aerobic and resistance exercise program or home-based progressive stretching program. All study activities will be conducted remotely using digital technologies and home-based assessments. Participants in both groups will receive Bluetooth-enabled wearable devices for monitoring physical activity, body weight, blood pressure, and other health measures.
The primary objective is to determine whether exercise improves chemotherapy relative dose intensity compared with stretching. The intervention will continue throughout chemotherapy treatment or for up to 32 weeks.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Abigail Tice, Ph.D.
- 邮箱:Abigail.Tice@AdventHealth.com
研究联系人备份
- 姓名:Marcus Perez
- 电话号码:407-303-5642
- 邮箱:Marcus.Perez@AdventHealth.com
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Gastrointestinal cancer (esophageal, gastric, pancreatic, colon, and rectal) treated with chemotherapy (and other treatments, as clinically indicated) before surgery OR Lung cancer (non-small cell and small-cell) treated with chemotherapy (and other treatments, as clinically indicated) for advanced- or extensive-stage disease.
- Completion of the modified version of the Physical Activity Readiness Questionnaire.
Exclusion Criteria:
- Actively treated for another non-gastrointestinal or non-lung malignancy (surveillance with observation is allowed).
- Engage in more than 150 minutes per week of aerobic physical activity and two or more sessions of muscle strengthening activity per week over the last three months (self-report).
- Unable to walk for 6 minutes or two city blocks independently (self-report).
- Enrollment in another study that intervenes upon physical activity, diet, or body composition as a primary objective (self-report).
- Unable to read and speak English.
- No access to a reliable internet connection.
- Currently an AdventHealth employee.
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Exercise
The exercise group will engage in aerobic and muscle-strengthening activities.
|
The exercise group will be provided with Bluetooth-enabled devices and home exercise equipment.
Participants will meet with an exercise trainer weekly to learn how to engage in the exercise program.
|
|
有源比较器:Stretching
The stretching group will engage in whole-body static stretching activities.
|
The stretching group will be provided with Bluetooth-enabled devices.
Participants will meet with an exercise trainer weekly to learn how to engage in the stretching program.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Chemotherapy Relative Dose Intensity
大体时间:Up to 32 weeks
|
The ratio of the delivered dose intensity to the standard or planned dose intensity.
|
Up to 32 weeks
|
合作者和调查者
调查人员
- 首席研究员:Justin Brown, Ph.D.、AdventHealth
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2376559
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.